Jackson, TENNESSEE8 Active Studies

Interstitial Cystitis Clinical Trials in Jackson, TENNESSEE

Find 8 actively recruiting interstitial cystitis clinical trials in Jackson, TENNESSEE. Connect with local research sites and explore new treatment options.

8
Active Trials
7
Sponsors
12,249
Enrolling

Recruiting Interstitial Cystitis Studies in Jackson

RecruitingJackson, TENNESSEENCT06468202

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

The overall goal of this large, pragmatic, comparative effectiveness trial is to test the hypothesis that among at-risk individuals, 162 mg/day aspirin is superior to 81 mg/day in preventing Hypertens...

10,742 participants
Ohio State University
View Study Details
RecruitingJackson, TENNESSEENCT06133972

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

The purpose of this study is to evaluate long-term safety and tolerability of ianalumab in participants with systemic lupus erythematosus who have previously completed the treatment period in one of t...

550 participants
Novartis Pharmaceuticals
View Study Details
RecruitingJackson, TENNESSEENCT06596252

Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE

The purpose of this study is to prove the non-inferiority of a 6-weeks treatment with 1 mg budesonide orodispersible tablets BID versus 2 mg budesonide orodispesible tabletss for the induction of clin...

308 participants
Dr. Falk Pharma GmbH
View Study Details
RecruitingJackson, TENNESSEENCT06832618

A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis

The purpose of the study is to assess the efficacy and safety of ruxolitinib cream in children and adolescents (6 to \<18 Years Old) with moderate atopic dermatitis....

240 participants
Incyte Corporation
View Study Details
RecruitingJackson, TENNESSEENCT05930210

A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer

This Phase 3 study is a randomized, double-blind, vehicle-controlled, multiple-center, parallel study to evaluate efficacy and safety of ENERGI-F703 GEL compared with vehicle control in subjects with ...

230 participants
Energenesis Biomedical Co., Ltd.
View Study Details
RecruitingJackson, TENNESSEENCT02323399

Study to Determine the Pharmacokinetics and Pharmacodynamic Effects of Phenylephrine on BP Via IV

The primary objective of this study is to evaluate the dose effect of Phenylephrine Hydrochloride Injection on the treatment of clinically relevant decreased blood pressure in the pediatric population...

100 participants
West-Ward Pharmaceutical
View Study Details
RecruitingJackson, TENNESSEENCT04925479

Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia

The aim of this study is to support development of asciminib in the pediatric population (1 to \<18 years) previously treated with one or more TKIs. Full extrapolation of the efficacy of asciminib fro...

44 participants
Novartis Pharmaceuticals
View Study Details
RecruitingJackson, TENNESSEENCT06875960

A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132

The purpose of this study is to allow the continued administration of Deucravacitinib in participants with Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (...

35 participants
Bristol-Myers Squibb
View Study Details

About Interstitial Cystitis Clinical Trials in Jackson

Interstitial cystitis/bladder pain syndrome is a chronic condition causing bladder pressure, bladder pain, and sometimes pelvic pain. It primarily affects women and can significantly impact quality of life. Treatment includes dietary changes, bladder instillations, oral medications, and neuromodulation.

There are currently 8 interstitial cystitis clinical trials recruiting participants in Jackson, TENNESSEE. These studies are seeking a combined 12,249 participants. Research is being sponsored by Ohio State University, Novartis Pharmaceuticals, Dr. Falk Pharma GmbH and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Cystitis Clinical Trials in Jackson — FAQ

Are there interstitial cystitis clinical trials in Jackson?

Yes, there are 8 interstitial cystitis clinical trials currently recruiting in Jackson, TENNESSEE. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Jackson?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Jackson research site will contact you about next steps.

Are clinical trials in Jackson free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Jackson studies also compensate for your time and travel.

What interstitial cystitis treatments are being tested?

The 8 active trials in Jackson are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial cystitis.

Data updated March 2, 2026 from ClinicalTrials.gov